Linked Data API

Show Search Form

Search Results

1140582
star this property registered interest false more like this
star this property date less than 2019-07-19more like thismore than 2019-07-19
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when he plans to issue guidance to health professionals on the Serious Shortage Protocol. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 279389 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-26more like thismore than 2019-07-26
star this property answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-07-26T11:34:54.427Zmore like thismore than 2019-07-26T11:34:54.427Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy remove filter
star this property previous answer version
131086
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1140584
star this property registered interest false more like this
star this property date less than 2019-07-19more like thismore than 2019-07-19
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what plans the Government has provide information to patients on changes to the provision of medicines as a result of the serious shortage protocol; and if he will make a statement. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 279390 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-26more like thismore than 2019-07-26
star this property answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 279391 more like this
star this property question first answered
less than 2019-07-26T11:36:12.94Zmore like thismore than 2019-07-26T11:36:12.94Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy remove filter
star this property previous answer version
131087
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1140585
star this property registered interest false more like this
star this property date less than 2019-07-19more like thismore than 2019-07-19
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Drugs more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what discussions the Government has had with (a) patient groups and (b) professional bodies on the development of the serious shortage protocol. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 279391 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-26more like thismore than 2019-07-26
star this property answer text <p>A Serious Shortage Protocol is an additional tool to manage serious medication shortages and may be used in the exceptional and rare situation when other measures have been exhausted or are likely to be ineffective.</p><p>At present we are currently working on the governance process for developing Serious Shortage Protocols, should one be required, through engagement, including with professional bodies and patient groups. Following this we will issue guidance to health professionals in due course.</p><p>The Pharmaceutical Services Negotiating Committee, the organisation who represent National Health Service community pharmacy contractors in England, have developed a briefing note to support community pharmacies, who will need to consider training and changes to their standard operating-procedures to take account of the potential new processes.</p><p>Any Serious Shortage Protocol would be developed by senior, specialist doctors and pharmacists, with input from national experts, Royal Colleges and specialist societies. If a Serious Shortage Protocol is to be authorised then there will also be engagement with the relevant patient groups, who can assist in informing patients. Pharmacists still have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate and provide the patient with relevant information. If they determine supply is not appropriate, then the patient should be referred back to their prescriber.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 279390 more like this
star this property question first answered
less than 2019-07-26T11:36:13.003Zmore like thismore than 2019-07-26T11:36:13.003Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy remove filter
star this property previous answer version
131085
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1137560
star this property registered interest false more like this
star this property date less than 2019-07-08more like thismore than 2019-07-08
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Sexually Transmitted Infections more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the correlation between reductions to public health funding and increases in rates of syphilis and gonorrhoea. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 274471 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-11more like thismore than 2019-07-11
star this property answer text <p>We estimate that increases in rates of syphilis, gonorrhoea and chlamydia are due to a number of factors. These include increases in both the number of people attending sexual health services and the number of tests for sexually transmitted infections. Public Health England has advised that other factors include, better detection of infection and behavioural changes such as an increase in partner numbers and condomless sex, as well as, for some men who have sex with men, ‘chemsex’ and group sex facilitated by geosocial networking applications.</p><p> </p><p>Local authorities will receive £3.1 billion in 2019/20, ring-fenced exclusively for use on public health, including sexual health. We are investing over £16 billion in local authority public health services over the five years of the 2015 Spending Review until 2020/21. It is for individual local authorities to decide their spending priorities based on an assessment of local need, including the need for sexual health services taking account of their statutory duties.</p><p> </p><p>Local authorities are required by regulations to provide comprehensive open access sexual health services, including provision for sexually transmitted infection testing and treatment and contraception.</p><p> </p><p>The latest statistics show that more people are now accessing sexual health services. Attendances have increased by 7% between 2017 and 2018 (from 3,337,677 to 3,561,548). This continues the trend of increases in attendances seen over the past five years. To help manage the overall increase in demand, local authorities are increasingly commissioning online services to manage lower risk and asymptomatic patients. These services have the potential to reach groups not currently engaged with clinic services.</p><p> </p><p> </p><p> </p><p> </p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-07-11T13:19:43.073Zmore like thismore than 2019-07-11T13:19:43.073Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy remove filter
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1137563
star this property registered interest false more like this
star this property date less than 2019-07-08more like thismore than 2019-07-08
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Preventive Medicine: Finance more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether the Green Paper on Prevention will include and assessment of the level of funding required to implement the contents of that Green Paper. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 274472 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-11more like thismore than 2019-07-11
star this property answer text <p>We are considering a number of policy options for the Prevention Green Paper and will be mindful of the level of funding that may be required for their implementation.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-07-11T13:32:12.653Zmore like thismore than 2019-07-11T13:32:12.653Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy remove filter
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1137564
star this property registered interest false more like this
star this property date less than 2019-07-08more like thismore than 2019-07-08
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Genito-urinary Medicine and HIV Infection more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether the Prevention Green Paper will include (a) commitments on additional resources to tackle HIV and (b) targets to improve sexual health. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 274473 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-11more like thismore than 2019-07-11
star this property answer text <p>We are considering a range of policy options for the Green Paper and will be mindful of HIV and sexual health.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-07-11T13:32:41.76Zmore like thismore than 2019-07-11T13:32:41.76Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy remove filter
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1128556
star this property registered interest false more like this
star this property date less than 2019-05-23more like thismore than 2019-05-23
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Influenza: Vaccination more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when his Department plans to publish data on the uptake of influenza vaccinations by social care workers in 2018-19. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 257680 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-05more like thismore than 2019-06-05
star this property answer text <p>There is no nationally agreed data set or data collection for recording the immunisation of social care workers.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-05T15:16:16.713Zmore like thismore than 2019-06-05T15:16:16.713Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy remove filter
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1121453
star this property registered interest false more like this
star this property date less than 2019-04-11more like thismore than 2019-04-11
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Vaccination: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, pursuant to his oral contribution on 26 March 2019 to Question 910028 on Antimicrobial Resistance: Vaccines, what steps his Department is taking to stimulate research and development into vaccines, including for tuberculosis, as an alternative to antibiotics. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 244039 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-04-24more like thismore than 2019-04-24
star this property answer text <p>The United Kingdom national action plan on antimicrobial resistance (AMR), published on 24 January 2019, contains the commitment to continue to support research into new and alternative treatments, vaccines and diagnostic tests.</p><p>The Government has invested over £350 million in AMR research and development since 2014, including research funding calls with vaccination in scope, most recently the £32 million capital funding call lead by the National Institute for Health Research (NIHR), and the Small Business Research Initiative competition which announced its awards in January 2019. We would expect to consider the role of vaccines for AMR in future programmatic funding.</p><p>The UK supports the development of vaccines through UK Aid programmes such as the Global AMR Innovation Fund (GAMRIF) and the UK Vaccine Network. GAMRIF is a £50 million fund to support innovative research and development for AMR, for the benefit of people in low- and middle-income countries, and invests £30 million into preventative measures in human and animal health, including vaccines for AMR not including tuberculosis (TB). The fund includes a £1 million work package with the Bacterial Vaccinology Network which supports early stage research and development around the world to drive the development and uptake of vaccines for AMR in humans and animals.</p><p>The UK supports TB vaccine research through the Medical Research Council (MRC), with support to the European and Developing Countries Clinical Trials Partnership, and through the Joint Global Health Clinical Trials programme represented by the Department for International Development (DFID), MRC, NIHR and Wellcome. DFID’s Agriculture research team is supporting work on bovine TB vaccine development in partnership with the Bill and Melinda Gates Foundation.</p><p> </p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 244040 more like this
star this property question first answered
less than 2019-04-24T08:08:02.973Zmore like thismore than 2019-04-24T08:08:02.973Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy remove filter
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this
1121454
star this property registered interest false more like this
star this property date less than 2019-04-11more like thismore than 2019-04-11
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Vaccination: Research more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, pursuant to his oral contribution on 26 March 2019 to Question 910028 on Antimicrobial Resistance: Vaccines, what funding he plans to make to stimulate research and development into vaccines as an alternative to antibiotics. more like this
star this property tabling member constituency North Norfolk more like this
star this property tabling member printed
Norman Lamb remove filter
star this property uin 244040 more like this
unstar this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-04-24more like thismore than 2019-04-24
star this property answer text <p>The United Kingdom national action plan on antimicrobial resistance (AMR), published on 24 January 2019, contains the commitment to continue to support research into new and alternative treatments, vaccines and diagnostic tests.</p><p>The Government has invested over £350 million in AMR research and development since 2014, including research funding calls with vaccination in scope, most recently the £32 million capital funding call lead by the National Institute for Health Research (NIHR), and the Small Business Research Initiative competition which announced its awards in January 2019. We would expect to consider the role of vaccines for AMR in future programmatic funding.</p><p>The UK supports the development of vaccines through UK Aid programmes such as the Global AMR Innovation Fund (GAMRIF) and the UK Vaccine Network. GAMRIF is a £50 million fund to support innovative research and development for AMR, for the benefit of people in low- and middle-income countries, and invests £30 million into preventative measures in human and animal health, including vaccines for AMR not including tuberculosis (TB). The fund includes a £1 million work package with the Bacterial Vaccinology Network which supports early stage research and development around the world to drive the development and uptake of vaccines for AMR in humans and animals.</p><p>The UK supports TB vaccine research through the Medical Research Council (MRC), with support to the European and Developing Countries Clinical Trials Partnership, and through the Joint Global Health Clinical Trials programme represented by the Department for International Development (DFID), MRC, NIHR and Wellcome. DFID’s Agriculture research team is supporting work on bovine TB vaccine development in partnership with the Bill and Melinda Gates Foundation.</p><p> </p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 244039 more like this
star this property question first answered
less than 2019-04-24T08:08:03.02Zmore like thismore than 2019-04-24T08:08:03.02Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy remove filter
star this property tabling member
1439
unstar this property label Biography information for Norman Lamb more like this